I[NTRODUCTION]{.smallcaps} {#sec1-1}
==========================

Gastroesophageal reflux disease (GERD) is a common disorder and requires substantial medical resources worldwide \[[@ref1]\]. The incidence is increasing in most western and some Asian countries \[[@ref2]\]. The prevalence is as high as 25% in Taiwan \[[@ref3]\]. It can affect the quality of life, with complications such as esophagitis, ulcers, bleeding, strictures, Barrett\'s esophagus, and adenocarcinoma \[[@ref4][@ref5][@ref6]\]. The diagnosis depends on typical symptoms such as heartburn and acid regurgitation. However, not all symptomatic patients have esophageal mucosal injury on endoscopy \[[@ref7]\]. The pathogenesis may be multifactorial affecting mainly the lower esophageal sphincter \[[@ref8]\]. The use of a proton pump inhibitor is the gold standard treatment for relief of reflux symptoms and healing of the mucosal injury. However, the therapeutic response is still unsatisfactory especially for those patients with nonacidic reflux or esophageal hypersensitivity. Research on new compounds and identifying the risk factors of GERD would be helpful in the treatment of refractory GERD \[[@ref9][@ref10][@ref11]\].

Several risk factors such as obesity and hiatus hernia have been associated with the development of GERD \[[@ref9][@ref10][@ref11]\]. However, the role of popular beverages in the development of GERD is still controversial. Coffee and tea are the most popular beverages in the world. People initially drink coffee or tea because of the taste and fragrance. The health benefits of these beverages have been explored in recent years. Coffee had been reported to reduce the risk of metabolic syndrome (MS), Alzheimer\'s disease, and colon cancer \[[@ref12][@ref13][@ref14][@ref15]\]. Health benefits have also been found from green and black tea \[[@ref16]\]. Green tea can improve MS and obesity \[[@ref17]\]. However, studies assessing the association of coffee and tea with GERD are scarce and findings have been inconsistent \[[@ref18]\]. In addition, whether additives such as milk or sugar have any impact on GERD has never been discussed. Thus, we performed a cross-sectional study using a large-scale health checkup cohort to clarify whether the consumption of tea and coffee and additives affects the development of GERD.

M[ATERIALS AND METHODS]{.smallcaps} {#sec1-2}
===================================

Study participants {#sec2-1}
------------------

A total of 2604 participants who underwent an upper gastrointestinal endoscopy during a health checkup at the Health Examination Center of Taipei Tzu Chi Hospital from March 2012 to August 2013 were enrolled prospectively. Participants with missing clinical or biochemical data (*n* = 445) or incomplete answers about their coffee or tea consumption (*n* = 322) were excluded from the study. Each participant completed the reflux disease questionnaire (RDQ). The RDQ was previously validated as an instrument for the diagnosis of symptomatic GERD \[[@ref10][@ref11][@ref19]\]. The Clinical and biochemical data and information on coffee and tea consumption were collected. Coffee or tea drinking was defined as drinking the beverage at least 4 days/week for 3 months. Heavy coffee or tea consumption was defined as drinking at least two cups every day. Sugar or milk use was defined *t* as use of the additive more than 80% of the time. The Ethics Committees of Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation approved this study and each participant provided informed consent (01-XD08-013).

Reflux disease questionnaire and endoscopic findings {#sec2-2}
----------------------------------------------------

In our study, a face-to-face interview was performed during the health checkup, and the questionnaire was completed at the same interview. The RDQ was designed to assess the symptoms of heartburn, acid regurgitation, and dyspepsia. It includes 12 questions on the frequency and severity of burning and pain behind the breastbone, an acid taste in the mouth, movement of materials upward from stomach, and burning and pain in the upper stomach \[[@ref20][@ref21]\]. Responses range from 0 to 5 points. After excluding the dyspepsia scale, scores for the RDQ range from 0 to 40. Symptomatic GERD is defined as mild reflux symptoms at least two times/week or moderate reflux symptoms at least once per week. An esophagogastroduodenoscopy was performed on each participant under sedation. Experienced endoscopists were performed all procedures and were blinded to the results of the questionnaire. Erosive esophagitis (EE) on endoscopy was graded from A to D according to the Los Angeles classification \[[@ref22]\]. Another experienced endoscopist reviewed the endoscopic imaging to confirm a diagnosis of EE. If there was disagreement on the diagnosis, the final diagnosis was made by consensus of three experienced endoscopists.

Personal and medical information {#sec2-3}
--------------------------------

Personal data, including age, gender, body mass index (BMI), and history of hyperlipidemia, diabetes mellitus, hypertension, smoking, alcohol drinking, and use of aspirin and a nonsteroidal anti-inflammatory drugs (NSAIDs), were collected. The definition of alcohol drinking in our study was drinking alcohol at least once per week. The use of aspirin and an NSAID was defined as having taken these drugs in the previous 3 months. An automatic analyzer measured serum fasting blood glucose, total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein (HDL), and triglycerides (TGs) (Roche Analytics; Roche Professional Diagnostics, Penzberg, Germany). *Helicobacter pylori* infection was assessed by a rapid urease test during the esophagogastroduodenoscopy.

Statistical analysis {#sec2-4}
--------------------

We used SAS Version 9.2 (SAS Institute, Cary, NC, USA) to perform all analyses. Continuous data were presented as mean with standard deviations while categorical data were presented as percentages. The Chi-square test and Student\'s *t*-test were applied to analyze continuous and categorical variables. The association of potential risk factors with symptomatic GERD or EE was determined using multivariate analysis. *P* \< 0.05 was considered statistically significant.

R[ESULTS]{.smallcaps} {#sec1-3}
=====================

Personal and clinical data from the study samples {#sec2-5}
-------------------------------------------------

A total of 1837 participants were recruited for the final analysis. Of these, 1197 (65.2%) drank coffee, of which 185 (15.5%) participants were heavy coffee drinkers. In total, 538 (44.9%) subjects added milk to their coffee and 340 (28.4%) participants added sugar. A total of 1215 (66.1%) participants drank tea. Of these, 275 (22.6%) participants were defined as heavy tea drinkers. In total, 49 (4%) participants added sugar to their tea. *H. pylori* were positive in 493 (26.8%) participants. Altogether 467 (25.4%) participants were diagnosed with symptomatic GERD based on RDQ scores and 427 (23.2%) participants had EE on endoscopy. The relationship between reflux symptoms and EE is presented in [Table 1](#T1){ref-type="table"}. The percentage of consistence between reflux symptoms and EE EE was 65.6%. Personal and clinical data stratified by gender are shown in [Table 2](#T2){ref-type="table"}. In our study samples, men had higher percentages of heavy tea drinking, smoking, alcohol consumption, use of aspirin, hypertension, hyperlipidemia, *H. pylori* infection, hiatus hernia, and EE; however, a lower percentage of adding milk to coffee than women. Furthermore, men had higher BMIs, and glucose and TG levels, but lower HDL levels than women.

###### 

Relationship between reflux symptoms and erosive esophagitis in the study samples

  Gastroesophageal reflux disease   Erosive esophagitis (*n*=427), *n* (%)   No erosive esophagitis (*n*=1410), *n* (%)
  --------------------------------- ---------------------------------------- --------------------------------------------
  Yes, *n*=467                      131 (28.05)                              336 (71.95)
  No, *n*=1370                      296 (21.61)                              1074 (78.39)

###### 

Personal and clinical data of the study samples stratified by gender

                                    *n*=1837              Male, *n*=970         Female, *n*=867       *P*
  --------------------------------- --------------------- --------------------- --------------------- ---------
  Age                                                                                                 
   Mean±SD                          51.57±10.21           51.72±10.38           51.41±10.03           0.508
   Median (range)                   53 (20.03-70)         53 (20.03-70)         52.93 (20.97-70)      
  Age \<65                          1704 (92.76)          887 (91.44)           817 (94.23)           0.021
  BMI                                                                                                 
   Mean±SD                          23.85±3.55            24.75±3.43            22.85±3.42            \<0.001
   Median (range)                   23.53 (15.32-45.48)   24.38 (15.32-39.89)   22.39 (15.60-45.48)   
  BMI \<25                          1239 (67.45)          566 (58.35)           673 (77.62)           \<0.001
  Tea, *n* (%)                                                                                        
   No                               622 (33.86)           277 (28.56)           345 (39.79)           \<0.001
   Yes                              1215 (66.14)          693 (71.44)           522 (60.21)           
  Heavy tea (\>2/day), *n* (%)                                                                        
   No                               1562 (85.03)          796 (82.06)           766 (88.35)           \<0.001
   Yes                              275 (14.97)           174 (17.94)           101 (11.65)           
  Sugar with tea, *n* (%)\*                                                                           
   No                               1138 (93.66)          644 (92.93)           494 (94.64)           0.277
   Yes (≥4)                         77 (6.34)             49 (7.07)             28 (5.36)             
  Coffee, *n* (%)                                                                                     
   No                               640 (34.84)           329 (33.92)           311 (35.87)           0.380
   Yes                              1197 (65.16)          641 (66.08)           556 (64.13)           
  Heavy coffee (\>2/day), *n* (%)                                                                     
   No                               1652 (89.93)          865 (89.18)           787 (90.77)           0.256
   Yes                              185 (10.07)           105 (10.82)           80 (9.23)             
  Milk with coffee (%)\*                                                                              
   No                               651 (54.39)           367 (57.25)           284 (51.08)           0.032
   Yes (≥4)                         546 (45.61)           274 (42.75)           272 (48.92)           
  Sugar with coffee, *n* (%)\*                                                                        
   No                               846 (70.68)           439 (68.49)           407 (73.20)           0.074
   Yes (≥4)                         351 (29.32)           202 (31.51)           149 (26.80)           
  Smoking, *n* (%)                                                                                    
   No                               1646 (89.60)          803 (82.78)           843 (97.23)           \<0.001
   Yes                              191 (10.40)           167 (17.22)           24 (2.77)             
  Alcohol, *n* (%)                                                                                    
   No                               1715 (93.36)          868 (89.48)           847 (97.69)           \<0.001
   Yes                              122 (6.64)            102 (10.52)           20 (2.31)             
  Diabetes mellitus, *n* (%)                                                                          
   No                               1715 (93.36)          898 (92.58)           817 (94.23)           0.155
   Yes                              122 (6.64)            72 (7.42)             50 (5.77)             
  Hypertension, *n* (%)                                                                               
   No                               1488 (81.00)          746 (76.91)           742 (85.58)           \<0.001
   Yes                              349 (19.00)           224 (23.09)           125 (14.42)           
  Hyperlipidemia, *n* (%)                                                                             
   No                               1663 (90.53)          863 (88.97)           800 (92.27)           0.016
   Yes                              174 (9.47)            107 (11.03)           67 (7.73)             
  Aspirin, *n* (%)                                                                                    
   No                               1783 (97.06)          931 (95.98)           852 (98.27)           0.004
   Yes                              54 (2.94)             39 (4.02)             15 (1.73)             
  NSAID, *n* (%)                                                                                      
   No                               1744 (94.94)          916 (94.43)           828 (95.50)           0.297
   Yes                              93 (5.06)             54 (5.57)             39 (4.50)             
  TG                                                                                                  
   Mean±SD                          112.16±71.43          123.36±79.71          99.63±58.39           \<0.001
   Median (range)                   93 (19-641)           102.5 (20-641)        85 (19-421)           
  TG \<150                          1447 (78.77)          711 (73.30)           736 (84.89)           \<0.001
  Cholesterol                                                                                         
   Mean±SD                          188.50±38.46          185.69±38.48          191.65±38.21          0.001
   Median (range)                   186 (79-384)          182 (97-384)          189 (79-353)          
  Cholesterol \<200                 1176 (64.02)          636 (65.57)           540 (62.28)           0.143
  HDL                                                                                                 
   Mean±SD                          50.76±15.39           44.80±12.51           57.42±15.57           \<0.001
   Median (range)                   49 (16-178)           43 (16-102)           56 (22-178)           
  HDL ≥40                           1357 (73.87)          587 (60.52)           770 (88.81)           \<0.001
  LDL                                                                                                 
   Mean±SD                          120.53±33.02          121.88±32.99          119.01±33.01          0.062
   Median (range)                   119 (22-281)          120 (26-281)          117 (22-255)          
  LDL \<130                         1186 (64.56)          611 (62.99)           575 (66.32)           0.136
  Glucose                                                                                             
   Mean±SD                          97.86±22.14           98.94±24.69           96.65±18.82           0.025
   Median (range)                   94 (60-318)           94 (60-318)           93 (60-284)           
  Glucose \<100                     1299 (70.71)          672 (69.28)           627 (72.32)           0.153
  HbA1C                                                                                               
   Mean±SD                          5.62±1.33             5.68±1.71             5.56±0.69             0.032
   Median (range)                   5.5 (3.9-50)          5.5 (3.9-50)          5.5 (3.9-13)          
  HbA1C \<6                         1526 (83.07)          795 (81.96)           731 (84.31)           0.179
  Helicobacter pylori, *n* (%)                                                                        
   Negative                         1344 (73.16)          688 (70.93)           656 (75.66)           0.022
   Positive                         493 (26.84)           282 (29.07)           211 (24.34)           
  Hiatus hernia, *n* (%)                                                                              
   Negative                         1772 (96.46)          926 (95.46)           846 (97.58)           0.014
   Positive                         65 (3.54)             44 (4.54)             21 (2.42)             
  GERD, *n* (%)                                                                                       
   No                               1370 (74.58)          727 (74.95)           643 (74.16)           0.700
   Yes                              467 (25.42)           243 (25.05)           224 (25.84)           
  Erosive esophagitis, *n* (%)                                                                        
   No                               1410 (76.76)          693 (71.44)           717 (82.70)           \<0.001
   Yes                              427 (23.24)           277 (28.56)           150 (17.30)           

\*Percentages were obtained from the population that drank tea or coffee. BMI: Body mass index, NSAID: Nonsteroid anti-inflammatory drug, TG: Triglyceride, HDL: High-density lipoprotein, LDL: Low-density lipoprotein, HbA1C: Glycated hemoglobin, GERD: Gastroesophageal reflux disease, SD: Standard deviation

Clinical characteristics of patients with gastroesophageal reflux disease and erosive esophagitis {#sec2-6}
-------------------------------------------------------------------------------------------------

There were significant differences regarding adding milk to coffee, serum TG level \<150, serum LDL level \<130, and the presence of *H. pylori* between those with and without symptomatic GERD. There were no significant differences in these groups for tea drinking, heavy tea drinking, adding sugar to tea, coffee drinking, heavy coffee drinking, adding sugar to coffee or drinking "tea and coffee." There were significant differences regarding gender, BMI \<25, drinking "tea and coffee," smoking, hypertension, hyperlipidemia, TG levels \<150, HDL levels \>40, HbA1c levels \< 6, *H. pylori*, and hiatus hernia between subjects with and without EE. There were no significant differences in tea drinking, heavy tea drinking, adding sugar to tea, coffee drinking, heavy coffee drinking, adding milk to coffee, adding sugar to coffee, or drinking "tea and coffee" \[[Table 3](#T3){ref-type="table"}\].

###### 

Comparison of clinical characteristics of between patients with and without symptomatic gastroesophageal reflux disease or erosive esophagitis

                                  Symptomatic GERD   Erosive esophagitis                                        
  ------------------------------- ------------------ --------------------- ------- ------------- -------------- ---------
  Age\<65                         442 (94.65)        1262 (92.12)          0.068   395 (92.51)   1309 (92.84)   0.817
  Sex, male                       243 (52.03)        727 (53.07)           0.700   150 (35.13)   717 (50.85)    \<0.001
  BMI\<25                         303 (64.88)        936 (68.32)           0.171   249 (58.31)   990 (70.21)    \<0.001
  Tea, yes                        319 (68.31)        896 (65.40)           0.252   274 (64.17)   941 (66.74)    0.326
  Heavy tea (\>2/day), yes        68 (14.56)         207 (15.11)           0.774   64 (14.99)    211 (14.96)    0.990
  Sugar with tea (≥4), yes\*      23 (7.21)          54 (6.03)             0.456   19 (6.93)     58 (6.16)      0.645
  Coffee, yes                     317 (67.88)        880 (64.23)           0.153   269 (63.00)   928 (65.82)    0.284
  Heavy coffee (\>2/day), yes     48 (10.28)         137 (10.00)           0.863   43 (10.07)    142 (10.07)    1.000
  Milk with coffee (≥4), yes\*    161 (50.79)        385 (43.75)           0.031   117 (43.49)   429 (46.23)    0.428
  Sugar with coffee (≥4), yes\*   105 (33.12)        246 (27.95)           0.083   78 (29.00)    273 (29.42)    0.894
  Tea and coffee, yes             257 (55.03)        694 (50.66)           0.102   202 (47.31)   749 (53.12)    0.035
  Smoking                         55 (11.78)         136 (9.93)            0.258   62 (14.52)    129 (9.15)     0.001
  Alcohol                         33 (7.07)          89 (6.50)             0.669   36 (8.43)     86 (6.10)      0.090
  Diabetes mellitus               33 (7.07)          89 (6.50)             0.669   32 (7.49)     90 (6.38)      0.419
  Hypertension                    78 (16.70)         271 (19.78)           0.143   97 (22.72)    252 (17.87)    0.025
  Hyperlipidemia                  48 (10.28)         126 (9.20)            0.491   54 (12.65)    120 (8.51)     0.011
  Aspirin                         16 (3.43)          38 (2.77)             0.471   12 (2.81)     42 (2.98)      0.857
  NSAID                           27 (5.78)          66 (4.82)             0.412   20 (4.68)     73 (5.18)      0.684
  TG (\<150)                      352 (75.37)        1095 (79.93)          0.038   304 (71.19)   1143 (81.06)   \<0.001
  Cholesterol (\<200)             289 (61.88)        887 (64.74)           0.266   261 (61.12)   915 (64.89)    0.155
  HDL (≥40)                       339 (72.59)        1018 (74.31)          0.466   281 (65.81)   1076 (76.31)   \<0.001
  LDL (\<130)                     275 (58.89)        911 (66.50)           0.003   265 (62.06)   921 (65.32)    0.218
  Glucose (\<100)                 327 (70.02)        972 (70.95)           0.704   308 (72.13)   991 (70.28)    0.462
  HbA1C (\<6)                     388 (83.08)        1138 (83.07)          0.993   339 (79.39)   1187 (84.18)   0.021
  Helicobacter pylori             107 (22.91)        386 (28.18)           0.027   77 (18.03)    416 (29.50)    \<0.001
  Hiatus hernia                   17 (3.64)          48 (3.50)             0.890   53 (12.41)    12 (0.85)      \<0.001

\*Percentages were obtained from the population that drank tea or coffee. GERD: Gastroesophageal reflux disease, BMI: Body mass index, NSAID: Nonsteroid anti-inflammatory drug, HDL: High-density lipoprotein, LDL: Low-density lipoprotein, HbA1C: Glycated hemoglobin, TG: Triglyceride

Factors associated with reflux symptoms and erosive esophagitis on endoscopy using multivariate analysis {#sec2-7}
--------------------------------------------------------------------------------------------------------

Multivariate analysis showed that LDL levels \<130 and *H. pylori* infection were associated with reflux symptoms. Female gender, BMI \<25, *H. pylori* infection, and hiatus hernia were associated with EE \[[Table 4](#T4){ref-type="table"}\].

###### 

Factors associated with gastroesophageal reflux disease and erosive esophagitis using multivariate analysis

                                GERD               Erosive esophagitis                                                                                  
  ----------------------------- ------------------ --------------------- ------------------ ------- -------------------- --------- -------------------- ---------
  Age \<65                      1.51 (0.97-2.37)   0.070                                            0.95 (0.63-1.44)     0.817                          
  Sex, female                   1.04 (0.84-1.29)   0.700                                            0.52 (0.42-0.66)     \<0.001   0.60 (0.46-0.77)     \<0.001
  BMI \<25                      0.86 (0.69-1.07)   0.171                                            0.59 (0.47-0.74)     \<0.001   0.73 (0.56-0.94)     0.016
  Tea, yes                      1.14 (0.91-1.43)   0.252                 1.13 (0.87-1.46)   0.362   0.89 (0.71-1.12)     0.326     0.86 (0.65-1.13)     0.284
  Heavy tea (\>2/day), yes      0.96 (0.71-1.29)   0.774                 0.91 (0.66-1.25)   0.561   1.00 (0.74-1.36)     0.990     0.93 (0.65-1.31)     0.663
  Sugar with tea (≥4), yes      1.21 (0.73-2.01)   0.457                                            1.13 (0.66-1.94)     0.645                          
  Coffee, yes                   1.18 (0.94-1.47)   0.153                 1.11 (0.86-1.43)   0.410   0.88 (0.71-1.11)     0.284     0.90 (0.69-1.18)     0.463
  Heavy coffee (\>2/day), yes   1.03 (0.73-1.46)   0.863                 0.99 (0.69-1.43)   0.974   1.00 (0.70-1.43)     1.000     0.97 (0.65-1.46)     0.887
  Milk with coffee (≥4), yes    1.33 (1.03-1.72)   0.031                                            0.90 (0.68-1.18)     0.428                          
  Sugar with coffee (≥4), yes   1.28 (0.97-1.68)   0.083                                            0.98 (0.73-1.32)     0.894                          
  Tea and coffee, yes           1.19 (0.97-1.47)   0.102                                            0.79 (0.64-0.98)     0.035                          
  Smoking                       1.21 (0.87-1.69)   0.258                                            1.69 (1.22-2.33)     0.002     1.32 (0.92-1.90)     0.136
  Alcohol                       1.09 (0.72-1.66)   0.669                 1.07 (0.70-1.62)   0.751   1.42 (0.95-2.13)     0.091                          
  Diabetes mellitus             1.09 (0.72-1.66)   0.669                                            1.19 (0.78-1.81)     0.420                          
  Hypertension                  0.81 (0.62-1.07)   0.144                                            1.35 (1.04-1.76)     0.026     1.02 (0.75-1.38)     0.911
  Hyperlipidemia                1.13 (0.80-1.61)   0.491                                            1.56 (1.11-2.19)     0.011     1.11 (0.75-1.65)     0.591
  Aspirin                       1.24 (0.69-2.25)   0.472                                            0.94 (0.49-1.81)     0.857                          
  NSAIDs                        1.21 (0.76-1.92)   0.412                                            0.90 (0.54-1.49)     0.684                          
  TG \<150                      0.77 (0.60-0.99)   0.038                 0.80 (0.62-1.03)   0.086   0.58 (0.45-0.74)     \<0.001   0.78 (0.58-1.04)     0.091
  Cholesterol \<200             0.88 (0.71-1.10)   0.266                                            0.85 (0.68-1.06)     0.155                          
  HDL ≥40                       0.92 (0.72-1.16)   0.466                                            0.60 (0.47-0.76)     \<0.001   0.92 (0.69-1.22)     0.546
  LDL \<130                     0.72 (0.58-0.90)   0.003                 0.74 (0.59-0.92)   0.006   0.87 (0.69-1.09)     0.218                          
  Glucose \<100                 0.96 (0.76-1.20)   0.704                                            1.09 (0.86-1.39)     0.462                          
  HbA1C \<6                     1.00 (0.76-1.32)   0.993                                            0.72 (0.55-0.95)     0.021     0.84 (0.62-1.14)     0.256
  Helicobacter pylori           0.76 (0.59-0.97)   0.027                 0.75 (0.59-0.96)   0.023   0.53 (0.40-0.69)     \<0.001   0.53 (0.40-0.70)     \<0.001
  Hiatus hernia                 1.04 (0.59-1.83)   0.890                                            16.51 (8.73-31.21)   \<0.001   13.80 (7.20-26.45)   \<0.001

GERD: Gastroesophageal reflux disease, BMI: Body mass index, NSAIDs: Nonsteroid anti-inflammatory drugs, HDL: High-density lipoprotein, LDL: Low-density lipoprotein, HbA1C: Glycated hemoglobin, OR: Odds ratio, CI: Confidence interval, TG: Triglyceride

Factors associated with erosive esophagitis using multivariate analysis stratified by gender {#sec2-8}
--------------------------------------------------------------------------------------------

In our study samples, *H. pylori* infection and hiatus hernia were associated with EE in men. BMI \<25, use of aspirin and hiatus hernia were associated with EE in women \[[Table 5](#T5){ref-type="table"}\].

###### 

Factors associated with erosive esophagitis on endoscopy using multivariate analysis stratified by gender

                                Male                 Female                                                                                       
  ----------------------------- -------------------- --------- -------------------- --------- -------------------- --------- -------------------- ---------
  Age \<65                      0.98 (0.60-1.61)     0.940                                    1.10 (0.51-2.40)     0.802                          
  BMI \<25                      0.89 (0.67-1.18)     0.417                                    0.39 (0.26-0.56)     \<0.001   0.42 (0.27-0.65)     \<0.001
  Tea, yes                      0.87 (0.64-1.17)     0.354     0.94 (0.66-1.35)     0.744     0.76 (0.53-1.08)     0.128     0.78 (0.50-1.21)     0.263
  Heavy tea (\>2/day), yes      0.88 (0.61-1.27)     0.495     0.89 (0.59-1.36)     0.594     1.04 (0.61-1.79)     0.883     1.05 (0.57-1.93)     0.869
  Sugar with tea (≥4), yes      0.84 (0.43-1.64)     0.602                                    1.86 (0.76-4.53)     0.171                          
  Coffee, yes                   0.89 (0.67-1.20)     0.449     0.86 (0.61-1.22)     0.407     0.84 (0.58-1.20)     0.331     0.98 (0.63-1.52)     0.924
  Heavy coffee (\>2/day), yes   0.95 (0.60-1.49)     0.822     0.86 (0.52-1.43)     0.558     1.02 (0.55-1.86)     0.961     1.16 (0.60-2.26)     0.658
  Milk with coffee (≥4), yes    1.13 (0.80-1.60)     0.486                                    0.67 (0.43-1.06)     0.086                          
  Sugar with coffee (≥4), yes   1.00 (0.69-1.45)     0.986                                    0.85 (0.50-1.43)     0.537                          
  Tea and coffee, yes           0.88 (0.66-1.16)     0.354                                    0.60 (0.42-0.87)     0.006                          
  Smoking                       1.51 (1.06-2.15)     0.021     1.43 (0.97-2.09)     0.070     0.43 (0.10-1.84)     0.253     0.62 (0.14-2.71)     0.527
  Alcohol                       1.10 (0.71-1.73)     0.664                                    1.61 (0.58-4.51)     0.361                          
  Diabetes mellitus             0.89 (0.52-1.53)     0.672                                    1.74 (0.90-3.37)     0.098                          
  Hypertension                  1.00 (0.72-1.39)     0.996                                    1.92 (1.23-2.99)     0.004     1.27 (0.77-2.09)     0.356
  Hyperlipidemia                1.51 (0.99-2.29)     0.057                                    1.42 (0.78-2.60)     0.254                          
  Aspirin                       0.44 (0.18-1.07)     0.070                                    3.28 (1.15-9.35)     0.026     3.79 (1.26-11.34)    0.017
  NSAID                         0.78 (0.41-1.49)     0.454                                    1.05 (0.45-2.42)     0.913                          
  TG \<150                      0.64 (0.47-0.87)     0.004     0.72 (0.51-1.01)     0.059     0.62 (0.40-0.97)     0.038     0.85 (0.52-1.41)     0.531
  Cholesterol \<200             0.76 (0.57-1.01)     0.059                                    0.95 (0.66-1.37)     0.792                          
  HDL ≥40                       0.75 (0.57-0.99)     0.048     0.88 (0.64-1.21)     0.435     0.64 (0.38-1.05)     0.079                          
  LDL \<130                     0.89 (0.67-1.18)     0.420                                    0.88 (0.61-1.28)     0.509                          
  Glucose \<100                 1.10 (0.81-1.50)     0.528                                    1.16 (0.77-1.73)     0.480                          
  HbA1C \<6                     0.74 (0.52-1.05)     0.096                                    0.73 (0.46-1.15)     0.178                          
  Helicobacter pylori           0.44 (0.31-0.62)     \<0.001   0.47 (0.33-0.67)     \<0.001   0.64 (0.41-0.99)     0.048     0.67 (0.42-1.07)     0.092
  Hiatus hernia                 15.11 (6.65-34.34)   \<0.001   13.20 (5.75-30.32)   \<0.001   17.00 (6.13-47.20)   \<0.001   15.86 (5.54-45.40)   \<0.001

BMI: Body mass index, NSAID: Nonsteroid anti-inflammatory drug, HDL: High-density lipoprotein, LDL: Low-density lipoprotein, HbA1C: Glycated hemoglobin, TG: Triglyceride, OR: Odds ratio, CI: Confidence interval

D[ISCUSSION]{.smallcaps} {#sec1-4}
========================

In this study of 1837 participants from a health examination center, 467 (25.4%) were diagnosed as having symptomatic GERD according to RDQ scores and 427 (23.3%) had EE on endoscopy. Serum LDL levels and *H. pylori* infection were associated with reflux symptoms. Gender, BMI, *H. pylori* infection, and hiatus hernia were associated with EE on endoscopy. Our data concluded that drinking tea or coffee, and adding sugar or milk was not associated with reflux symptoms or EE.

GERD is diagnosed based on typical reflux symptoms including heartburn and/or regurgitation. The prevalence of GERD ranges from 2.5% to 33.1% in different areas of the world \[[@ref23]\]. A previous Taiwanese study reported that the prevalence of GERD was 25% in the community \[[@ref3]\]. The prevalence of GERD in our study was 25.4%, which is consistent with the previous report. In GERD patients, reflux symptoms had incomplete correspondence with EE on endoscopy. A population-based endoscopic study showed that two-thirds of the patients reporting reflux symptoms had no EE \[[@ref24]\]. Our previous study found that 14.5% of an asymptomatic population had EE \[[@ref11]\]. In our study samples, 71.95% of symptomatic GERD patients had nonerosive reflux disease and asymptomatic EE was found in 21.61% of the asymptomatic population. Our study similarly found incomplete correspondence between reflux symptoms and EE.

Food, beverages, and lifestyle have impacts on the development of GERD \[[@ref25][@ref26][@ref27][@ref28]\]. Some previous studies reported a therapeutic effect of tea on *H. pylori* infection and peptic ulcer \[[@ref29][@ref30][@ref31]\]. However, the role of tea, and coffee in the development of GERD is controversial \[[@ref32][@ref33]\] For example, a cross-sectional questionnaire study found 23.4% of 2853 participants had GERD. They found green tea drinkers had a higher risk of GERD with an odds ratio of 1.44 \[[@ref34]\]. However, a Chinese cohort study including 8831 retirees found no significant association between tea and reflux symptoms \[[@ref35]\]. In addition, an Indian study in a high altitude area revealed that salt tea had a protective effect against GERD \[[@ref36]\]. Another German study using an ambulatory pH meter showed that coffee, but not tea increased gastroesophageal reflux \[[@ref37]\]. Coffee was found to be a risk factor for GERD in some studies \[[@ref32][@ref33]\]. In contrast, a case--control study including 3153 individuals showed a negative association between exposure to coffee and reflux symptoms \[[@ref25]\]. These inconsistent findings can be attributed to the different types of tea and coffee or the study population. In addition, additives, such as sugar or milk, were not discussed. Our survey revealed that tea, coffee, and added sugar or milk were not associated with reflux symptoms or EE.

*H. pylori* infection may protect against the development of GERD and its complications \[[@ref38][@ref39]\]. Hiatus hernia is known to be a major risk factor in GERD development \[[@ref40][@ref41][@ref42][@ref43]\]. Our study consistently found that the presence of hiatus hernia increased the risk of EE. In contrast, *H. pylori* infection seems to protect an individual from development of reflux symptoms and EE.

A Taiwanese study recruiting 1238 residents in a community revealed female gender, age of 40--49 years, and age of 50--59 years were independent risk factors for GERD \[[@ref3]\]. However, a systemic review did not find that female gender was a risk factor of GERD \[[@ref1]\]. Our results showed that women had a lower risk of EE, but not associated with reflux symptoms. Except for hiatus hernia, the risk factors for EE were different between *t* genders. *H. pylori* infection was associated with EE in men, but BMI and use of aspirin showed an association in women. The complex associations among gender, risk factors, and GERD need further investigation. Although older patients may underreport reflux symptoms, two European studies revealed a trend of older patients with a high prevalence of GERD \[[@ref44][@ref45]\]. Our results showed that older age was not associated with reflux symptoms and EE.

Obesity, especially abdominal obesity may increase intragastric pressure, the gastroesophageal gradient, transient lower esophageal sphincter relaxation, and the duration of esophageal acid exposure and is currently considered a risk factor of for EE \[[@ref9][@ref46]\]. Our study found that BMI was associated with EE in women.

Our study has several strengths. This is the first study to investigate tea, coffee, and additives such as sugar or milk in the development of GERD. In addition, since our study included the results of a questionnaire and endoscopic findings, the risk factors for reflux symptoms or EE could be identified. However, some limitations should be acknowledged. First, we only recorded the number of cups of coffee or tea per day, but not the strength of the coffee or tea. Furthermore, the types of tea such as green, black, or salt tea were not included in our questionnaire. Second, some medications are known to increase the risk of reflux symptoms and esophageal mucosal injury \[[@ref47]\]. Although the medication history, except for aspirin and NSAIDS, was not recorded in our study, this confounding effect might be minimal due to the relatively healthy condition of our study samples from a health examination center. Finally, since our study was cross-sectional, causal relationships cannot be determined.

In summary, drinking tea or coffee and adding sugar or milk was not associated with reflux symptoms or EE. Factors associated with reflux symptoms and EE included metabolic factors and hiatus hernia. In contrast, female gender and *H. pylori* infection seem to have a protective to against the development of EE.
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